NEW_CURA-LEAF_1170x120_OCT

Alex Azar

NACDS, NCPA applaud letter to Azar

NACDS, NCPA applaud letter to Azar

WASHINGTON — The National Association of Chain Drug Stores and the National Community Pharmacists Association (NCPA) have praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar. The letter thanked the secretary for concepts in the Centers for Medicare and Medicaid Services’ (CMS’) proposed rule, Modernizing Part D and Medicare Advantage to

NACDS, NCPA praise senate action to reduce patient drug costs

NACDS, NCPA praise senate action to reduce patient drug costs

WASHINGTON — The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) Tuesday praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar. The letter thanked the Secretary for concepts in the Centers for Medicare & Medicaid Services’ (CMS) proposed rule, Modernizing Part D and Medicare Advantage

Prices boosted on hundreds of drugs

Prices boosted on hundreds of drugs

NEW YORK — Drugmakers are increasing the price of hundreds of drugs by an average of more than 6%, according to a new analysis by Rx Savings Solutions. With pressure on the pharmaceutical industry to hold down prices mounting, many of the increases are relatively small. But some generics are seeing steep hikes, and overall

Health leaders visit community pharmacy owners to promote “gag clause” ban

Health leaders visit community pharmacy owners to promote “gag clause” ban

PITTSBURGH  – U.S. Department of Health and Human Services secretary Alex Azar and Paul Mango, chief principal deputy administrator and chief of staff in the Centers for Medicare and Medicaid Services’ Office of the Administrator, today visited Spartan Pharmacy in Pittsburgh as part of ongoing efforts to highlight President Trump’s signing into law legislation to ban

NACDS issues memo to chain members on administration’s drug pricing policies

NACDS issues memo to chain members on administration’s drug pricing policies

ARLINGTON, Va. — NACDS today sent the following memo to chain members: We are writing to update you on President Trump’s announcement today regarding prescription drug pricing policies, and anticipated future events related to it. In short, we anticipate learning more details in the coming days, and NACDS will analyze the Administration’s proposals and provide

NACDS praises Congress’ call for DIR fee reform

NACDS praises Congress’ call for DIR fee reform

ARLINGTON, Va. — In the growing effort to achieve pro-patient and pro-pharmacy reforms of direct and indirect remuneration (DIR) fees in Medicare Part D, the National Association of Chain Drug Stores today hailed a letter to Health and Human Services Secretary Alex Azar signed by 50 members of the U.S. House of Representatives and led

NACDS members have a lot to offer in opioid fight

NACDS members have a lot to offer in opioid fight

ARLINGTON, Va. — The National Association of Chain Drug Stores took part in this month’s White House Opioid Summit as it continues to give retail pharmacy’s take on how to combat the opioid abuse epidemic. Kevin Nicholson, vice president of public policy and regulatory affairs at NACDS, represented the association at the March 1 event,

Trump makes cutting high drug prices a priority

Trump makes cutting high drug prices a priority

WASHINGTON — In his first State of the Union speech, President Donald Trump renewed his pledge to reduce prescription drug prices, days after a former big pharma executive was sworn in as Secretary of Health and Human Services. Trump had stunned the pharmaceutical industry during his 2016 campaign by declaring that drug manufacturers were “getting

Senate confirms Alex Azar as HHS secretary

Senate confirms Alex Azar as HHS secretary

WASHINGTON — Former Eli Lilly and Co. executive Alex Azar has been confirmed by the Senate as the new secretary of the U.S. Department of Health & Human Services (HHS). Nominated for the HHS secretary post in November by President Donald Trump, Azar was approved by the Senate on Wednesday in a 55-43 vote, mainly

Senators grill HHS nominee Alex Azar on cutting drug costs

Senators grill HHS nominee Alex Azar on cutting drug costs

WASHINGTON — Alex Azar, a former pharmaceutical executive named by President Trump to be the next Health and Human Services secretary, told senators at a full committee nomination hearing that making prescription drugs more affordable would be one of his top priorities. “Drug prices are too high,” Azar said to the Senate health committee at

Former Lilly exec Alex Azar tabbed to head HHS

Former Lilly exec Alex Azar tabbed to head HHS

WASHINGTON — Biopharmaceutical industry executive Alex Azar has been nominated as secretary of the U.S. Department of Health and Human Services (HHS) to fill the post vacated by Tom Price. Azar is currently founder and chairman of Seraphim Strategies LLC, an Indianapolis-based consultancy focused on the biopharma and health insurance industries, including biopharmaceutical sales, marketing, pricing,